Your Grapefruit Habit Could Be Making Your Medication Deadly
If you eat grapefruit or drink grapefruit juice while taking certain common medications, you may be flooding your body with dangerously high drug levels —...
Category caregivers
New Enzyme Replacement Therapy Approved for Ultra-Rare Condition
On February 23, 2026, the FDA granted accelerated approval to Loargys (pegzilarginase-nbln), the first and only injectable enzyme replacement therapy for...
New Gout Drug Finally Approved After Years of Waiting
After years of limited options for patients with severe, treatment-resistant gout, a new biologic therapy called NASP is on the verge of FDA approval,...
New Drug for Kidney Disease Slows Progression — Cardiologists Love It Too
A single drug now does what used to require separate treatments for kidneys and heart. On January 28, 2025, the FDA approved Ozempic (semaglutide) as the...
What Happens to Your Body When You Stop a Weight Loss Injection
When you stop a weight loss injection like semaglutide or tirzepatide, your body begins reversing course almost immediately.
The New FDA-Approved Weight Loss Pill — No Injection Required
On December 22, 2025, the FDA approved the first oral GLP-1 receptor agonist for weight management — a pill form of Wegovy (semaglutide) made by Novo...
Epilepsy Drug Approved for Rare Genetic Condition — A Breakthrough for Patients
A new class of epilepsy drugs is reaching patients with rare genetic conditions, and the results are striking.
Aduhelm Controversy: Why the FDA Approval Divided the Medical World
The FDA's approval of Aduhelm on June 7, 2021 divided the medical world because the agency overrode its own advisory committee — which had voted 10 to 1...
What Happens When Biologics Stop Working for Autoimmune Disease
When biologics stop working for autoimmune disease, patients face a frustrating but surprisingly common reality: an estimated 30 to 40 percent of people...
New Lupus Drug Gets Approval — First of Its Kind in Years
The FDA approved Gazyva (obinutuzumab) on October 20, 2025, for adult patients with active lupus nephritis — making it only the third drug ever greenlit...